92 related articles for article (PubMed ID: 7590862)
1. Role of newly synthesized MHC class II molecules in antigen-specific antigen presentation by B cells.
Kokuho T; Nariuchi H; Gyotoku Y; Kakiuchi T
Immunobiology; 1995 Jun; 193(1):42-58. PubMed ID: 7590862
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by brefeldin A of the specific B cell antigen presentation to MHC class II-restricted T cells.
Kakiuchi T; Takatsuki A; Watanabe M; Nariuchi H
J Immunol; 1991 Nov; 147(10):3289-95. PubMed ID: 1940337
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of specific and nonspecific antigen-presentation by B cells to a protein synthesis inhibitor.
Kakiuchi T; Watanabe M; Hozumi N; Nariuchi H
J Immunol; 1990 Sep; 145(6):1653-8. PubMed ID: 2391415
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity to antigenic competition in antigen-specific and -nonspecific antigen presentation by B cells.
Kakiuchi T; Okada Y; Kokuho T; Gyotoku Y; Mizuguchi J; Nariuchi H
Immunobiology; 1995 Jun; 193(1):84-97. PubMed ID: 7590865
[TBL] [Abstract][Full Text] [Related]
5. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.
St-Pierre Y; Watts TH
J Immunol; 1990 Aug; 145(3):812-8. PubMed ID: 2373860
[TBL] [Abstract][Full Text] [Related]
6. Selective enhancement of B cell antigen receptor-mediated antigen presentation by treatment with transforming growth factor-beta.
Arai C; Ichijo T; Tanaka Y; Okada Y; Umeda M; Uchida T; Kiniwa M; Kakiuchi T
Eur J Immunol; 2003 Jul; 33(7):1806-15. PubMed ID: 12811840
[TBL] [Abstract][Full Text] [Related]
7. Presentation of antigens internalized through the B cell receptor requires newly synthesized MHC class II molecules.
Forquet F; Barois N; Machy P; Trucy J; Zimmermann VS; Leserman L; Davoust J
J Immunol; 1999 Mar; 162(6):3408-16. PubMed ID: 10092796
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
St Pierre Y; Watts TH
J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
10. Artificial T cell:B cell conjugation. A unique approach to analyze weak cell-cell interactions.
Cassatt DR; Kaplan AM; Cohen DA
J Immunol; 1988 Sep; 141(5):1437-44. PubMed ID: 2457614
[TBL] [Abstract][Full Text] [Related]
11. Direct involvement of surface IA/E molecules during B cell maturation using an antigen-specific B cell clone.
Hamano T; Iwasaki T; Yamasaki T; Murata Y; Kakishita E; Nagai K
J Immunol; 1990 Feb; 144(3):811-5. PubMed ID: 2295818
[TBL] [Abstract][Full Text] [Related]
12. The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock.
Michalek MT; Benacerraf B; Rock KL
J Immunol; 1992 Feb; 148(4):1016-24. PubMed ID: 1737924
[TBL] [Abstract][Full Text] [Related]
13. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
14. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
Cheng PC; Steele CR; Gu L; Song W; Pierce SK
J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
[TBL] [Abstract][Full Text] [Related]
15. Beta 2-adrenoceptor stimulation increases the number of antigen-specific precursor B lymphocytes that differentiate into IgM-secreting cells without affecting burst size.
Sanders VM; Powell-Oliver FE
J Immunol; 1992 Mar; 148(6):1822-8. PubMed ID: 1311733
[TBL] [Abstract][Full Text] [Related]
16. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of antigen-presenting ability of B lymphoma cells by partial inhibition of protein synthesis through inducing B7-1 expression.
Aoi T; Nakano H; Tanaka Y; Kakiuchi T
Immunology; 1997 Jun; 91(2):212-8. PubMed ID: 9227319
[TBL] [Abstract][Full Text] [Related]
18. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma.
Frandji P; Oskéritzian C; Cacaraci F; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
J Immunol; 1993 Dec; 151(11):6318-28. PubMed ID: 8245470
[TBL] [Abstract][Full Text] [Related]
19. Weak base amines can inhibit class I MHC-restricted antigen presentation.
Michalek MT; Benacerraf B; Rock KL
J Immunol; 1991 Jan; 146(2):449-56. PubMed ID: 1987272
[TBL] [Abstract][Full Text] [Related]
20. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
